Preview

Russian neurological journal

Advanced search

Tuberculous sclerosis (Burneville disease): case report and modern aspects of diagnosis

https://doi.org/10.30629/2658-7947-2026-31-3-35-42

Abstract

Tuberous sclerosis complex (TSC), also known as Bourneville disease, is an autosomal dominant orphan disease belonging to the group of phakomatoses. Morphologically, TSC is characterized by systemic hamartomas. This article presents a case of a patient diagnosed with TSC at the age of 24 according to the 2021 International TSC Clinical Consensus criteria. The diagnosis of TSC was established by the presence of more than three hypomelanotic macules, multiple cortical tubers and radial migration lines, and more than two subependymal nodules. This case report provides an overview of the epidemiology, clinical features, and diff erential diagnosis of TSC. Furthermore, it discusses the actual diagnostic criteria, including the value of fi nding genetic variants of unknown signifi cance in the diagnosis of TSC.

About the Authors

M. Yu. Maksimova
Russian Center for Neurology and Neurosciences
Russian Federation

Moscow



E. M. Abbasova
Russian Center for Neurology and Neurosciences
Russian Federation

Moscow



U. R. Dukuev
Russian Center for Neurology and Neurosciences
Russian Federation

Moscow



E. V. Vasil’eva
Russian Center for Neurology and Neurosciences
Russian Federation

Moscow



References

1. Chen CS, Aylett CHS. New insights into tuberous sclerosis complex: from structure to pathogenesis. Front Cell Dev Biol. 2025;13:1595867. doi: 10.3389/fcell.2025.1595867

2. Wataya-Kaneda M. Tuberous Sclerosis Complex. Keio J Med. 2025;74(1):42–51. doi: 10.2302/kjm.2023-0011-IR

3. Man A, Di Scipio M, Grewal S, Suk Y, Trinari E, Ejaz R, Whitney R. The Genetics of Tuberous Sclerosis Complex and Related mTORopathies: Current Understanding and Future Directions. Genes (Basel). 2024;15(3):332. doi: 10.3390/genes15030332

4. Tyburczy ME, Dies KA, Glass J, Camposano S, Chekaluk Y, Thorner AR, Lin L, Krueger D, Franz DN, Thiele EA, Sahin M, Kwiatkowski DJ. Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identifi ed by Conventional Testing. PLoS Genet. 2015;11(11):e1005637. doi: 10.1371/journal.pgen.1005637

5. Ye Z, Lin S, Zhao X, Bennett MF, Brown NJ, Wallis M, Gao X, Sun L, Wu J, Vedururu R, Witkowski T, Gardiner F, Stutterd C, Duan J, Mullen SA, McGillivray G, Bodek S, Valente G, Reagan M, Yao Y, Li L, Chen L, Boys A, Adikari TN, Cao D, Hu Z, Beshay V, Zhang VW, Berkovic SF, Scheff er IE, Liao J, Hildebrand MS. Mosaicism in tuberous sclerosis complex: Lowering the threshold for clinical reporting. Hum Mutat. 2022;43(12):1956–1969. doi: 10.1002/humu.24454

6. Krueger DA, Northrup H; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49(4):255–65. doi: 10.1016/j.pediatrneurol.2013.08.002

7. Northrup H, Aronow ME, Bebin EM, Bissler J, Darling TN, de Vries PJ, Frost MD, Fuchs Z, Gosnell ES, Gupta N, Jansen AC, Jóźwiak S, Kingswood JC, Knilans TK, McCormack FX, Pounders A, Roberds SL, Rodriguez-Buritica DF, Roth J, Sampson JR, Sparagana S, Thiele EA, Weiner HL, Wheless JW, Towbin AJ, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations. Pediatr Neurol. 2021;123:50–66. doi: 10.1016/j.pediatrneurol.2021.07.011

8. Peron A, Au KS, Northrup H. Genetics, genomics, and genotypephenotype correlations of TSC: Insights for clinical practice. Am J Med Genet C Semin Med Genet. 2018;178(3):281–290. doi: 10.1002/ajmg.c.31651

9. Specchio N, Nabbout R, Aronica E, Auvin S, Benvenuto A, de Palma L, Feucht M, Jansen F, Kotulska K, Sarnat H, Lagae L, Jozwiak S, Curatolo P. Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy. Eur J Paediatr Neurol. 2023;47:25–34. doi: 10.1016/j.ejpn.2023.08.005

10. Belousova ED, Vlodavets DV, Pivovarova AM, Katysheva OV, Dorofeeva M.Yu. Targeted therapy for tuberous sclerosis complex. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics. 2016;61(5):106–112. (In Russ.). https://doi.org/10.21508/1027-4065-2016-61-5-106-112

11. Belousova ED, Dorofeeva MY, Ohapkina TG. Treatment of epilepsy in tuberous sclerosis. Epilepsy and paroxysmal conditions. 2016;8(2):37–42. (In Russ.).

12. Zhang MN, Zou LP, Wang YY, Pang LY, Ma SF, Huang LL, Gao Y, Lu Q, Franz DN. Calcifi cation in cerebral parenchyma aff ects pharmacoresistant epilepsy in tuberous sclerosis. Seizure. 2018;60:86–90. doi: 10.1016/j.seizure.2018.06.011

13. Gallagher A, Madan N, Stemmer-Rachamimov A, Thiele EA. Progressive calcifi ed tuber in a young male with tuberous sclerosis complex. Dev Med Child Neurol. 2010;52(11):1062–5. doi: 10.1111/j.1469-8749.2010.03792.x

14. Boronat S, Caruso P, Auladell M, Van Eeghen A, Thiele EA. Arachnoid cysts in tuberous sclerosis complex. Brain Dev. 2014;36(9):801–6. doi: 10.1016/j.braindev.2013.11.003


Review

For citations:


Maksimova M.Yu., Abbasova E.M., Dukuev U.R., Vasil’eva E.V. Tuberculous sclerosis (Burneville disease): case report and modern aspects of diagnosis. Russian neurological journal. 2026;31(3):35-42. (In Russ.) https://doi.org/10.30629/2658-7947-2026-31-3-35-42

Views: 297

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2658-7947 (Print)
ISSN 2686-7192 (Online)